Back

Pharmacogenetic Characterization of Cytochrome P450 Genes involved in Psychotropic Medication Metabolism in a Cohort of Patients with Prader-Willi Syndrome

Moreno-Armengol, A.; Pareja, R.; Hernandez-Lazaro, A.; Capel, L.; Corripio, R.; Caixas, A.; Baena, N.

2026-05-18 pharmacology and therapeutics
10.64898/2026.05.09.26352521 medRxiv
Show abstract

Prader-Willi syndrome (PWS) is a rare multisystemic disorder characterized by obesity, endocrine dysfunctions, and psychiatric comorbidities, which imply frequent use of psychotropic medications. They account for atypical responses to standard dosages of psychiatric drugs. Pharmacogenetics could be part of the reason for this situation, potentially offering a valuable tool for individualized treatment. This study analyzed allelic and phenotypic frequency distributions of five of the main cytochrome P450 enzymes (CYP2D6, CYP2B6, CYP2C19, CYP2C9, CYP3A4) involved in psychiatric drug metabolism in 47 patients with genetically confirmed diagnosis of PWS and compared them to reference frequencies in the general European population. Allelic frequency comparisons between the European reference population and the overall PWS cohort revealed a significant global difference for CYP2B6, with CYP2C19 and CYP2D6 showing trends toward significance. Although no global allelic differences remained significant after false discovery rate correction, post-hoc analyses consistently identified an enrichment of reduced- or non-functional alleles CYP2B619 and CYP2D610 in patients with PWS. Predicted metabolizer phenotype analyses showed a significant shift toward intermediate metabolizers of CYP3A4 in the PWS cohort, with corresponding depletion of normal metabolizers. Subgroup analyses indicated that allelic differences were more pronounced in maternal uniparental disomy and non-deletion subtypes, particularly for CYP2B6, although no significant differences were observed between PWS genetic subtypes. Overall, results imply potential differences in metabolizing activity in PWS patients, and subsequent implications in drug efficacy and tolerability. These results support the idea that pharmacogenetic testing may improve therapeutic decision-making in PWS for psychiatric treatment. Larger studies are needed to confirm these preliminary results.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Clinical Pharmacology & Therapeutics
25 papers in training set
Top 0.1%
10.0%
2
Frontiers in Psychiatry
83 papers in training set
Top 0.4%
8.4%
3
NeuroImage: Clinical
132 papers in training set
Top 0.8%
6.3%
4
npj Genomic Medicine
33 papers in training set
Top 0.1%
6.3%
5
Translational Psychiatry
219 papers in training set
Top 1%
6.3%
6
Scientific Reports
3102 papers in training set
Top 31%
3.9%
7
British Journal of Clinical Pharmacology
21 papers in training set
Top 0.1%
3.6%
8
PLOS ONE
4510 papers in training set
Top 39%
3.6%
9
Epilepsia
49 papers in training set
Top 0.4%
3.6%
50% of probability mass above
10
International Journal of Molecular Sciences
453 papers in training set
Top 3%
2.9%
11
Journal of Clinical Medicine
91 papers in training set
Top 2%
2.7%
12
European Neuropsychopharmacology
15 papers in training set
Top 0.1%
2.7%
13
European Child & Adolescent Psychiatry
14 papers in training set
Top 0.2%
2.1%
14
Schizophrenia
19 papers in training set
Top 0.2%
2.1%
15
Epilepsy Research
12 papers in training set
Top 0.2%
1.9%
16
Clinical and Translational Science
21 papers in training set
Top 0.4%
1.8%
17
Genes
126 papers in training set
Top 1%
1.7%
18
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.2%
19
JMIRx Med
31 papers in training set
Top 1%
1.2%
20
Neurobiology of Disease
134 papers in training set
Top 3%
1.2%
21
BioData Mining
15 papers in training set
Top 0.5%
1.1%
22
BMJ Nutrition, Prevention & Health
10 papers in training set
Top 0.4%
0.9%
23
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
22 papers in training set
Top 0.3%
0.9%
24
The British Journal of Psychiatry
21 papers in training set
Top 0.8%
0.9%
25
eLife
5422 papers in training set
Top 56%
0.8%
26
International Journal of Neuropsychopharmacology
11 papers in training set
Top 0.2%
0.8%
27
Journal of Affective Disorders
81 papers in training set
Top 2%
0.7%
28
Genes, Brain and Behavior
29 papers in training set
Top 0.3%
0.7%
29
BMC Psychiatry
22 papers in training set
Top 0.8%
0.7%
30
Frontiers in Medicine
113 papers in training set
Top 7%
0.7%